| 000 | 01521 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513144215.0 | ||
| 264 | 0 | _c19980625 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0165-5728 | ||
| 024 | 7 |
_a10.1016/s0165-5728(97)00259-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrarini, A M | |
| 245 | 0 | 0 |
_aTime-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cApr 1998 |
||
| 300 |
_a213-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xchemistry |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-beta _xadministration & dosage |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _xanalysis |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSivieri, S | |
| 700 | 1 | _aBulian, P | |
| 700 | 1 | _aButtarello, M | |
| 700 | 1 | _aBiasi, G | |
| 700 | 1 | _aTavolato, B | |
| 700 | 1 | _aGallo, P | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 84 _gno. 2 _gp. 213-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-5728(97)00259-2 _zAvailable from publisher's website |
| 999 |
_c9594842 _d9594842 |
||